BioNTech SE (BNTX)
NASDAQ • Healthcare
October 23, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 3
in 9 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
BioNTech’s adjusted EPS missed consensus in the second fiscal quarter of 2026, based on preliminary results reported Aug. 4. Adjusted EPS came in at EUR -2.58 versus the EUR -2.40 estimate, about -7.6%, and was down from EUR -1.82 a year earlier. Operating income was a loss of about EUR 752.5 million, while net income fell 115.8% to a loss of about EUR 834.4 million from a loss of EUR 386.6 million a year ago. Operating cash flow was about EUR 11 million. Consensus for the next period calls for EPS of EUR 0.85 and revenue of EUR 1.22 billion.
Next report — what to expect
BioNTech SE (BNTX) reports on November 3, 2026. Wall Street is looking for consensus EPS of EUR 0.838 on consensus revenue of EUR 1.20 billion. For trailing context, revenue fell -59.5% year over year last quarter. BioNTech has beaten EPS in 6 of 8 most recent quarters.
About BioNTech SE
BioNTech SE (NASDAQ: BNTX) is a biotechnology company focused on immune-based treatments for cancer and infectious disease, spanning oncology programs, infectious-disease immunotherapies, and protein replacement therapies for rare conditions. The company generated EUR 2.8 billion of revenue in FY2025, with principal operations in Mainz, Germany.
Today's Snapshot
BNTX closed 1.7% below yesterday's close, in line with a weaker sector. Shares changed hands at about two-thirds of its usual level.
Trading Volume
Below 10d avg (1.3M)
837.8K
vs S&P 500 Today
Underperforming Market
-1.21%
Updated: October 23, 2026 at 20:22 UTC
BNTX Headlines
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$90.61 - $97.70Sell
- RSI (14)38.17Neutral
- Stochastic %K (14, 3, 3)18.43Buy
- MACD Level (12, 26)-2.49Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.